IGF2BP3 and acute myeloid leukemia: Moreover, upstream regulatory mechanisms of IGF2BPs were scarcely investigated in AML, while we found that IGF2BP2 and IGF2BP3 were driven by SEs, highlighting a novel and potential modulatory pattern of m6A‐binding proteins.